MDGL Madrigal Pharmaceuticals
- 267.790
- -8.220-2.98%
- 267.790
- 0.0000.00%
Madrigal Pharmaceuticals News
Madrigal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Waltermire Robert E.
Madrigal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Waltermire Robert E.
Madrigal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Madrigal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Madrigal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CRAVES FRED B
Madrigal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Madrigal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Madrigal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Madrigal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Madrigal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Waltermire Robert E.
Madrigal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CRAVES FRED B
Madrigal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Madrigal Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Madrigal Pharmaceuticals | 424B3: Prospectus
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 424B5: Prospectus
Madrigal Pharmaceuticals | 10-Q: Quarterly report
Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
Madrigal Pharmaceuticals | ARS: Annual Report to Security Holders
Madrigal Pharmaceuticals | DEFA14A: Others
Analysis
Price Target
No Data
